DD219768A5 - Verfahren zur herstellung von substituierten aethandiimidamid-zwischenprodukten, die zur herstellung von substitituierten 3,4-diamino-1,2,5-thiadiazolverbindungen dienen - Google Patents

Verfahren zur herstellung von substituierten aethandiimidamid-zwischenprodukten, die zur herstellung von substitituierten 3,4-diamino-1,2,5-thiadiazolverbindungen dienen Download PDF

Info

Publication number
DD219768A5
DD219768A5 DD83260707A DD26070783A DD219768A5 DD 219768 A5 DD219768 A5 DD 219768A5 DD 83260707 A DD83260707 A DD 83260707A DD 26070783 A DD26070783 A DD 26070783A DD 219768 A5 DD219768 A5 DD 219768A5
Authority
DD
German Democratic Republic
Prior art keywords
alkyl
general formula
compound
alkoxy
hydrogen atom
Prior art date
Application number
DD83260707A
Other languages
German (de)
English (en)
Inventor
Ronnie R Crenshaw
Aldo A Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DD219768A5 publication Critical patent/DD219768A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD83260707A 1982-03-29 1983-03-29 Verfahren zur herstellung von substituierten aethandiimidamid-zwischenprodukten, die zur herstellung von substitituierten 3,4-diamino-1,2,5-thiadiazolverbindungen dienen DD219768A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (1)

Publication Number Publication Date
DD219768A5 true DD219768A5 (de) 1985-03-13

Family

ID=23429274

Family Applications (2)

Application Number Title Priority Date Filing Date
DD83249300A DD210909A5 (de) 1982-03-29 1983-03-29 Verfahren zur herstellung von substituierten 3,4-diamino-1,2,5-thiadiazolverbindungen
DD83260707A DD219768A5 (de) 1982-03-29 1983-03-29 Verfahren zur herstellung von substituierten aethandiimidamid-zwischenprodukten, die zur herstellung von substitituierten 3,4-diamino-1,2,5-thiadiazolverbindungen dienen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DD83249300A DD210909A5 (de) 1982-03-29 1983-03-29 Verfahren zur herstellung von substituierten 3,4-diamino-1,2,5-thiadiazolverbindungen

Country Status (30)

Country Link
JP (2) JPS58180477A (sv)
KR (1) KR880002209B1 (sv)
AT (1) AT386599B (sv)
AU (2) AU557577B2 (sv)
BE (1) BE896291A (sv)
CH (2) CH660880A5 (sv)
CS (2) CS250240B2 (sv)
DD (2) DD210909A5 (sv)
DE (1) DE3311281A1 (sv)
DK (2) DK166677B1 (sv)
ES (3) ES8404683A1 (sv)
FR (2) FR2542741B1 (sv)
GB (2) GB2117769B (sv)
GR (1) GR78524B (sv)
HU (2) HU188742B (sv)
IE (1) IE55596B1 (sv)
IL (1) IL68259A0 (sv)
IT (1) IT1164633B (sv)
LU (1) LU84716A1 (sv)
MY (1) MY8700942A (sv)
NL (1) NL8301063A (sv)
NO (1) NO163055C (sv)
NZ (1) NZ203726A (sv)
OA (1) OA07356A (sv)
PT (1) PT76459B (sv)
SE (2) SE461040B (sv)
SU (2) SU1419518A3 (sv)
YU (1) YU44849B (sv)
ZA (1) ZA832154B (sv)
ZW (1) ZW7683A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
FI76795C (sv) * 1979-09-04 1988-12-12 Bristol Myers Co Förfarande för framställning av nya, terapeutiskt användbara 3,4-disub stituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanp rodukter
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
JPS58180477A (ja) 1983-10-21
IT8348005A0 (it) 1983-03-28
AU586037B2 (en) 1989-06-29
SU1419518A3 (ru) 1988-08-23
IE830686L (en) 1983-09-29
SE461040B (sv) 1989-12-18
ATA111083A (de) 1988-02-15
NZ203726A (en) 1986-05-09
CS250229B2 (en) 1987-04-16
ES8505977A1 (es) 1985-06-16
DE3311281A1 (de) 1983-11-24
GR78524B (sv) 1984-09-27
GB2117769B (en) 1985-08-29
NO163055C (no) 1990-03-28
HU188742B (en) 1986-05-28
PT76459B (en) 1986-03-11
YU74483A (en) 1986-02-28
ES8505978A1 (es) 1985-06-16
DK141383D0 (da) 1983-03-28
KR880002209B1 (ko) 1988-10-18
CS250240B2 (en) 1987-04-16
AT386599B (de) 1988-09-12
DK81192A (da) 1992-06-18
FR2542741B1 (fr) 1989-12-08
ES527685A0 (es) 1985-06-16
CH655111A5 (de) 1986-03-27
CH660880A5 (de) 1987-05-29
AU557577B2 (en) 1986-12-24
NO163055B (no) 1989-12-18
AU1290783A (en) 1983-10-06
GB8432809D0 (en) 1985-02-06
OA07356A (fr) 1984-08-31
ZW7683A1 (en) 1984-01-04
DK166677B1 (da) 1993-06-28
HU196386B (en) 1988-11-28
SE464302B (sv) 1991-04-08
PT76459A (en) 1983-04-01
YU44849B (en) 1991-04-30
SE8704689L (sv) 1987-11-25
JPH0568472B2 (sv) 1993-09-29
KR840004095A (ko) 1984-10-06
GB2149406A (en) 1985-06-12
IL68259A0 (en) 1983-06-15
GB2149406B (en) 1986-01-02
NO831100L (no) 1983-09-30
GB8308518D0 (en) 1983-05-05
NL8301063A (nl) 1983-10-17
SE8704689D0 (sv) 1987-11-25
AU6327286A (en) 1987-01-08
SU1355123A3 (ru) 1987-11-23
DD210909A5 (de) 1984-06-27
FR2597867B1 (fr) 1989-12-08
ES520982A0 (es) 1984-05-16
JPH06135925A (ja) 1994-05-17
DK81192D0 (da) 1992-06-18
SE8301725L (sv) 1983-11-25
BE896291A (fr) 1983-09-28
IT1164633B (it) 1987-04-15
IE55596B1 (en) 1990-11-21
GB2117769A (en) 1983-10-19
FR2597867A1 (fr) 1987-10-30
ZA832154B (en) 1983-12-28
ES8404683A1 (es) 1984-05-16
FR2542741A1 (fr) 1984-09-21
ES527686A0 (es) 1985-06-16
DK141383A (da) 1983-09-30
MY8700942A (en) 1987-12-31
LU84716A1 (fr) 1983-12-05
SE8301725D0 (sv) 1983-03-28

Similar Documents

Publication Publication Date Title
DE112005003227T5 (de) Neues Verfahren zur Herstellung von Pramipexol und dem Gemisch seiner optischen Isomeren durch Reduktion mit Natriumtriacetoxyborhydrid
DE60035109T2 (de) Verfahren zur herstellung von thiamethoxam
DD219768A5 (de) Verfahren zur herstellung von substituierten aethandiimidamid-zwischenprodukten, die zur herstellung von substitituierten 3,4-diamino-1,2,5-thiadiazolverbindungen dienen
DE1670679A1 (de) Verfahren zur Herstellung von Benzoxazin-Derivaten
DE69932938T2 (de) Verfahren zur herstellung eiens naphthyridincarbonsäurederivate (methansulfonat-sesquihydrat)
AT200578B (de) Verfahren zur Herstellung von neuen N-Aminoalkylderivaten von Azepinen
CH652125A5 (de) 1-substituierte n-(8alpha-ergolinyl)-n',n'-diaethylharnstoffe und verfahren zur herstellung derselben.
EP0285681B1 (de) Verfahren zur Herstellung von Nitroethenderivaten
DE68917333T2 (de) Heterocyclische Verbindungen und Antiulkusmittel.
DE2704934A1 (de) Organische verbindungen, ihre herstellung und verwendung
CH636856A5 (en) 4-(3-Aminopropoxy)indole derivatives, their preparation and medicines containing them
CH624672A5 (sv)
DE2406972C3 (de) Verfahren zur Herstellung von 5-Sulfamoylanthranilsäuren
DE69532533T2 (de) Verfahren zur herstellung von ranitidin
DE60206069T2 (de) Verfahren zur herstellung von n-alkyl-2-benzthiazolylsulfenimiden und verfahren zu deren aufreinigung
AT380019B (de) Verfahren zur herstellung von neuen thiadiazolderivaten
AT205976B (de) Verfahren zur Herstellung von neuen Nicotinsäurehydrazid-Derivaten
CH619236A5 (en) Process for the preparation of thienothiazine derivatives
AT332423B (de) Verfahren zur herstellung von neuen pyridylthioharnstoffen
DE2403060C3 (de) 3-Carbamoyl-1-thia-isochroman-1,1-dioxide und Verfahn zu ihrer Herstellung
AT268323B (de) Verfahren zur Herstellung von neuen 3,1-Benzothiazin-Derivaten und ihren Salzen
AT243445B (de) Verfahren zur Herstellung von neuen, am Stickstoff substituierten 3-(Dibenzo-[a,d]-1, 4-cycloheptadien-5-yloxy)-nortropanen und von Salzen dieser Verbindungen
AT379806B (de) Verfahren zur herstellung einer neuen thiadiazolverbindung
DE1643458C3 (de) N-(2-Alkoxybenzoyl)-p-aminobenzoesäure-aminoalkylester sowie deren quartäre Methylammoniumderivate und Verfahren zu ihrer Herstellung
AT224819B (de) Verfahren zur Herstellung des neuen N-Allyl-nor-atropins

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee